Ocean Biomedical(OCEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

OCEA Ocean Biomedical

Closed Good Friday 04-17 16:00:00 EDT

0.0415

-0.0017

-3.94%

盘后0.0402

-0.0014-3.25%

19:59 EDT

High0.0420	Low0.0370	Vol8.48M
Open0.0418	D1 Closing0.0432	Amplitude11.57%
Mkt Cap6.89M	Tradable Cap4.36M	Total Shares166.01M
T/O340.20K	T/O Rate8.08%	Tradable Shares105.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"OCEA","market":"US","secType":"STK","nameCN":"Ocean Biomedical","latestPrice":0.0415,"timestamp":1744920000000,"preClose":0.0432,"halted":0,"volume":8483795,"hourTrading":{"tag":"盘后","latestPrice":0.04015,"preClose":0.0415,"latestTime":"19:59 EDT","volume":176884,"amount":7208.067626,"timestamp":1744934367848},"delay":0,"floatShares":105000000,"shares":166010805,"eps":-0.344695,"marketStatus":"Closed Good Friday","change":-0.0017,"latestTime":"04-17 16:00:00 EDT","open":0.0418,"high":0.042,"low":0.037,"amount":340200.31524072,"amplitude":0.115741,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.344695,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0432,"preHourTrading":{"tag":"盘前","latestPrice":0.0416,"preClose":0.0432,"latestTime":"09:19 EDT","volume":148408,"amount":6216.217488,"timestamp":1744895991817},"postHourTrading":{"tag":"盘后","latestPrice":0.04015,"preClose":0.0415,"latestTime":"19:59 EDT","volume":176884,"amount":7208.067626,"timestamp":1744934367848},"volumeRatio":1.1867494404802428,"impliedVol":1.3446,"impliedVolPercentile":0.5896},"requestUrl":"/m/hq/s/OCEA","defaultTab":"news","newsList":[{"id":"2526514588","title":"Why this drone maker is braving turbulent markets for an IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2526514588","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526514588?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 01:21","pubTimestamp":1744305660,"startTime":"0","endTime":"0","summary":"Airo has launched a roadshow aiming to benefit from increased military spending around the world. Drone maker Airo Group Holdings Inc. is stepping into a challenging market for initial public offerings by launching a roadshow for its stock-market debut.Airo on Thursday said it plans to offer 5 million shares at an estimated price range of $14 to $15 a share for trading on the Nasdaq COMP under the symbol \"AIRO.\" . With up to 25.64 million shares of Airo to be outstanding after it goes public, the company would have a market capitalization of up to $410 million if the IPO prices at the top of its range.'Historically, IPO volume has dropped alongside spikes in volatility, sometimes for months, depending on the severity of the panic.'Renaissance Capital. The deal comes at a time when most IPOs have been delayed in the face of wild stock-market gyrations following President Trump's tariff moves in the past week.The Renaissance IPO ETF IPO was down 6.3% Thursday and has fallen 13.8% in the ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPHL","BK4008","BK4585","BK4167","MNTN","OCEA","UAL","BK4500","BK4588","BK4139"],"gpt_icon":1},{"id":"2524128523","title":"Ocean Biomedical Delays Yearly Report Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2524128523","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524128523?lang=en_us&edition=full_marsco","pubTime":"2025-04-02 02:17","pubTimestamp":1743531460,"startTime":"0","endTime":"0","summary":"Ocean Biomedical ( ($OCEA) ) has released a notification of late filing. Ocean Biomedical, Inc. has announced a delay in filing its Form 10-K (Year...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocean-biomedical-delays-yearly-report-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocean-biomedical-delays-yearly-report-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2522576119","title":"Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting Chi3l1 and Pd1 for Enhanced Tumor Cell Cytotoxicity in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2522576119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522576119?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:30","pubTimestamp":1743165031,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QB18M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2522799935","title":"Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2522799935","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522799935?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:30","pubTimestamp":1743165000,"startTime":"0","endTime":"0","summary":"PROVIDENCE, R.I., March 28, 2025  -- Ocean Biomedical, Inc. , a biopharmaceutical company dedicated to advancing innovative treatments for cancer, infectious diseases, and fibrosis, today announced that the China National Intellectual Property Administration  has granted a notice of grant on patent right for its bispecific antibodies targeting CHI3L1 and PD1, designed to enhance T cell-mediated cytotoxic effects on tumor cells.Current immunotherapies are often limited by tumor resistance and immune evasion mechanisms. Ocean Biomedical’s technology seeks to address these limitations by taking a multi-pronged approach, blocking two key pathways that tumors use to suppress the immune response. This could result in more robust and sustained tumor control, significantly improving survival rates for patients who currently have limited treatment options.The grant of this patent follows Ocean Biomedical’s continued success in securing intellectual property protection across key markets, includ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocean-biomedical-announces-grant-patent-123000737.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","OCEA","OCEAW"],"gpt_icon":0},{"id":"2517346386","title":"Trump's shipbuilding plan could upend ocean cargo industry, companies warn","url":"https://stock-news.laohu8.com/highlight/detail?id=2517346386","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517346386?lang=en_us&edition=full_marsco","pubTime":"2025-03-08 04:45","pubTimestamp":1741380319,"startTime":"0","endTime":"0","summary":"Trump's shipbuilding plan could upend ocean cargo industry, companies warnFees could backfire by swamping major U.S. seaports, imperiling exports and sticking everyday Americans with higher pricesMSC, the biggest container carrier, says it could skip small U.S. ports to reduce feesWorld Shipping Council calls on U.S. to reconsider planBy Lisa Baertlein. MSC, world's largest container carrier, could skip smaller ports like California's Port of Oakland - an important gateway for exports of fresh beef, dairy products and almonds - to mitigate the impact, Soren Toft, the company's CEO said at TPM. Such moves could swamp the nation's biggest ports and freeze out the smaller ones, risking a repeat of early pandemic backups that hobbled global trade flows, executives warned.\"It would be very difficult for us and our partners to absorb it all at once,\" Beth Rooney, director of the U.S. East Coast's largest port of New York and Jersey, said of the potential volume spike.PUNISHING UNKNOWN PAST M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL2N3PP0TA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU1066051498.USD","LU2361044865.SGD","BK0012","SG9999018865.SGD","LU0640476718.USD","LU0265550946.USD","BK0270","LU1064131342.USD","LU1989772840.SGD","LU1989772923.USD","LU2111349929.HKD","LU0985320562.USD","601919","BK0028","LU0265550359.USD","LU2361045086.USD","LU2430703178.SGD","LU2430703095.HKD","BK4139","BK4533","LU1116320737.USD","SG9999014898.SGD","LU2271345857.HKD","LU0345774631.USD","LU0868494617.USD","LU2089284900.SGD","BK0196","LU1804176565.USD","LU2764263039.SGD","LU0158827781.USD","SG9999018857.SGD","LU0310799852.SGD","BK4566","OCEA","LU1988902786.USD","LU0289960550.SGD","LU2461242641.AUD","GB00BDT5M118.USD","SPGI","LU0417517546.SGD","LU2125154778.USD","LU1280957306.USD","LU1989763005.USD","LU2089283258.USD","BK4155","LU2471134523.USD","BK0188","LU2750360641.GBP"],"gpt_icon":1},{"id":"2510338873","title":"Dow Falls 100 Points; Coca-Cola Posts Upbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338873","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510338873?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 23:12","pubTimestamp":1739286733,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43627094/dow-falls-100-points-coca-cola-posts-upbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLNC","HYPR","BHAT","PCOM","CMCO","OCEA","KO","SLQT"],"gpt_icon":1},{"id":"2510685446","title":"Ocean Biomedical announces findings in EGFR-mutant lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2510685446","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510685446?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:10","pubTimestamp":1739193007,"startTime":"0","endTime":"0","summary":"Ocean Biomedical (OCEA) announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy candidates to...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ocean-biomedical-announces-findings-in-egfr-mutant-lung-cancer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ocean-biomedical-announces-findings-in-egfr-mutant-lung-cancer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCEA","BK4139"],"gpt_icon":0},{"id":"2510854670","title":"BRIEF-Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2510854670","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510854670?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:08","pubTimestamp":1739192897,"startTime":"0","endTime":"0","summary":"BRIEF-Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer Feb 10 (Reuters) - Ocean Biomedical OCEA.O:OCEAN BIOMEDICAL ANNOUNCES BREAKTHROUGH FINDINGS IN EGFR-MUTANT LUNG CANCER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA3QMCZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OCEA"],"gpt_icon":1},{"id":"2510854620","title":"Ocean Biomedical- to Initiate Preclinical Studies to Advance Immunotherapy Program & to Engage With FDA for First-in-Human Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2510854620","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510854620?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:00","pubTimestamp":1739192402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA3QMCZM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2510548378","title":"Ocean Biomedical Announces Breakthrough Findings in Egfr-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2510548378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510548378?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:00","pubTimestamp":1739192402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250210:nTUA3QMCZM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2510854639","title":"Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2510854639","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510854639?lang=en_us&edition=full_marsco","pubTime":"2025-02-10 21:00","pubTimestamp":1739192400,"startTime":"0","endTime":"0","summary":"Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest. These findings, led by Ocean Biomedical’s Scientific Co-founder Dr. Jack A. Elias in collaboration with researchers at Yale University and Brown University, were published in Translational Oncology and mark the first description of the role of chitinase 3-like-1  in EGFR-mutant cancers. The research underscores the ability of Ocean Biomedical’s novel antibody to suppress CHi3L1 activity, leading to significant tumor reduction and, crucially, the reversal of drug resistance in preclinical models.Ocean has also developed bispecific antibodies that combine its anti-CHI3L1 antibody and anti-PD-1 or anti-CTLA4. Studies with these bispecific antibodies have highlighted their impressive efficacy in suppressing tumor growth and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocean-biomedical-announces-breakthrough-findings-130000492.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OCEA","SSI","OCEAW","BK4139"],"gpt_icon":0},{"id":"2507636544","title":"Ocean Biomedical Receives Additional NIH Funding for Malaria Vaccine Research; Shares Up Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2507636544","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507636544?lang=en_us&edition=full_marsco","pubTime":"2025-01-29 22:00","pubTimestamp":1738159236,"startTime":"0","endTime":"0","summary":"Ocean Biomedical  shares were up 88% premarket Wednesday after the company said that its co-founder, Jonathan Kurtis, and his research team have received additional funding from the National Institutes of Health to further their malaria vaccine research.The company said that recent US Food and Drug Administration guidance on lipid-encapsulated vaccines could provide an expedited development pathway for their approach.Ocean Biomedical said it could potentially begin human trials as early as Q4.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OCEA"],"gpt_icon":1},{"id":"2507483635","title":"Ocean Biomedical advances malaria vaccine research with new funding, pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2507483635","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507483635?lang=en_us&edition=full_marsco","pubTime":"2025-01-29 21:40","pubTimestamp":1738158036,"startTime":"0","endTime":"0","summary":"Ocean Biomedical (OCEA) announced that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional sign...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ocean-biomedical-advances-malaria-vaccine-research-with-new-funding-pathway?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ocean-biomedical-advances-malaria-vaccine-research-with-new-funding-pathway?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2507633082","title":"Ocean Biomedical Advances Malaria Vaccine Research With New Nih Funding and Expedited Development Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2507633082","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507633082?lang=en_us&edition=full_marsco","pubTime":"2025-01-29 21:31","pubTimestamp":1738157487,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nFWN3OP1MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OCEA"],"gpt_icon":0},{"id":"2507635912","title":"Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2507635912","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507635912?lang=en_us&edition=full_marsco","pubTime":"2025-01-29 21:30","pubTimestamp":1738157400,"startTime":"0","endTime":"0","summary":"Providence, RI, Jan. 29, 2025  -- Ocean Biomedical  announced today that its Scientific Co-founder, Dr. Jonathan Kurtis, MD, PhD, and his research team have received additional significant funding from the National Institutes of Health  to advance their groundbreaking malaria vaccine research. In parallel, recent U.S. Food and Drug Administration  Guidance on lipid-encapsulated vaccines may offer an expedited development pathway for their innovative approach.Malaria remains a devastating global health challenge, claiming the lives of over 500,000 children annually in sub-Saharan Africa. Despite hundreds of vaccine development efforts, few have succeeded, largely due to ineffective target selection strategies. Dr. Kurtis and his team have taken a novel approach by studying naturally occurring immune responses in children who have developed resistance to malaria.With the support of a $4.6 million non-governmental Foundation grant, Dr. Kurtis’ team is now testing three vaccine candidates ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocean-biomedical-advances-malaria-vaccine-133000576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","GARP","OCEAW","OCEA"],"gpt_icon":0},{"id":"2490085326","title":"Ocean Biomedical Inc - Receives Nasdaq Non-Compliance Notice for Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2490085326","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490085326?lang=en_us&edition=full_marsco","pubTime":"2024-12-10 05:32","pubTimestamp":1733779974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA1FW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCEA","BK4139"],"gpt_icon":0},{"id":"2485210248","title":"Ocean Biomedical Faces Nasdaq Delisting Threat","url":"https://stock-news.laohu8.com/highlight/detail?id=2485210248","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485210248?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 06:20","pubTimestamp":1732314018,"startTime":"0","endTime":"0","summary":"The latest update is out from Ocean Biomedical ( ($OCEA) ). Ocean Biomedical, Inc. faces potential delisting from Nasdaq after failing to file its ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ocean-biomedical-faces-nasdaq-delisting-threat?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ocean-biomedical-faces-nasdaq-delisting-threat?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2095319765.USD","LU2210149790.SGD","MNQmain","IE00B3QW5Z07.USD","OCEA","IE00BGHQF748.EUR","NQmain","BK4139","SQQQ","BK4112","QID","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","QLD","NDAQ","IE00B64PRP62.GBP","PSQ","TQQQ",".IXIC","BK4585"],"gpt_icon":0},{"id":"2485212740","title":"BRIEF-Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2485212740","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485212740?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 05:45","pubTimestamp":1732311947,"startTime":"0","endTime":"0","summary":"Nov 22 (Reuters) - Nasdaq Inc   :   * OCEAN BIOMEDICAL, INC. ANNOUNCES RECEIPT OF NOTICE FROM NASDAQ REGARDING LATE FILING OF QUARTERLY REPORT ON FORM 10-QSource text:    Further company coverage:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","LU0348723411.USD","LU1861215975.USD","QLD","LU1861220033.SGD","LU0124384867.USD","LU1720051108.HKD","LU2095319765.USD","MNQmain","LU0724618433.USD","IE00B3QW5Z07.USD","LU1720051017.SGD","NQmain","IE00BZ199S13.USD","BK4512","BK4588","TQQQ","BK4112","LU1861214812.USD","LU2210149790.SGD","OCEA","BK4585","IE00B64PRP62.GBP","LU1854104046.USD","LU1978683503.SGD","LU2210150020.SGD","LU1548497426.USD","NDAQ","BK4139","QID","BK4141","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU1854103824.USD","LU2360107325.USD","ON","PSQ","LU2298322129.HKD","LU2357305700.SGD","IE00BD6J9T35.USD","LU1861219969.SGD",".IXIC"],"gpt_icon":0},{"id":"2485212712","title":"Ocean Biomedical, Inc. Announces Receipt of Notice From Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2485212712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485212712?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 05:45","pubTimestamp":1732311900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241122:nTUA6JVYBG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2095319765.USD","BK4112","BK4588","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","OCEA","LU2210150020.SGD","LU2210149790.SGD","IE00BKPKM429.USD","NDAQ","BK4139","IE00BGHQF748.EUR","BK4585"],"gpt_icon":0},{"id":"2485217809","title":"Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2485217809","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485217809?lang=en_us&edition=full_marsco","pubTime":"2024-11-23 05:45","pubTimestamp":1732311900,"startTime":"0","endTime":"0","summary":"PROVIDENCE, Rhode Island, Nov.  22, 2024  (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), today announced that on November 18, 2024, it received a notice from The Nasdaq Stock Market LLC (“","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/22/2986221/0/en/Ocean-Biomedical-Inc-Announces-Receipt-of-Notice-from-Nasdaq-Regarding-Late-Filing-of-Quarterly-Report-on-Form-10-Q.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","OCEA","BK4139","MNQmain","SQQQ","BK4112",".IXIC","QID","BK4588","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","NDAQ","LU2095319765.USD","BK4585","LU2210149790.SGD","QLD","PSQ","TQQQ","LU2210150020.SGD","IE00BGHQF748.EUR","NQmain"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.oceanbiomedical.com","stockEarnings":[{"period":"1week","weight":-0.0525},{"period":"1month","weight":-0.2942},{"period":"3month","weight":-0.9231},{"period":"6month","weight":-0.9589},{"period":"1year","weight":-0.9768},{"period":"ytd","weight":-0.925}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.196091},{"month":2,"riseRate":0.5,"avgChangeRate":0.345099},{"month":3,"riseRate":0.5,"avgChangeRate":0.131512},{"month":4,"riseRate":0.5,"avgChangeRate":-0.209386},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.056755},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.011705},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.086073},{"month":8,"riseRate":0,"avgChangeRate":-0.021988},{"month":9,"riseRate":0,"avgChangeRate":-0.089496},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.222815},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.241434},{"month":12,"riseRate":0.25,"avgChangeRate":-0.092089}],"exchange":"NASDAQ","name":"Ocean Biomedical","nameEN":"Ocean Biomedical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ocean Biomedical(OCEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Ocean Biomedical(OCEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Ocean Biomedical,OCEA,Ocean Biomedical股票,Ocean Biomedical股票老虎,Ocean Biomedical股票老虎国际,Ocean Biomedical行情,Ocean Biomedical股票行情,Ocean Biomedical股价,Ocean Biomedical股市,Ocean Biomedical股票价格,Ocean Biomedical股票交易,Ocean Biomedical股票购买,Ocean Biomedical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ocean Biomedical(OCEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Ocean Biomedical(OCEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction